Answers are grounded in this paper and cite their sources.
Advances in drug development target liver injury, integrating natural products and network pharmacology, suggesting improved therapies.
In summary, the convergence of natural products, target-specific therapeutic strategies, and network pharmacology represents a promising direction in liver injury drug development. By addressing current limitations and harnessing emerging technologies, future research has the potential to fully realize the therapeutic value of these integrated approaches, ultimately advancing the development of more effective and personalized treatments for liver diseases.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: